Fig. 6
From: Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo
Biodistribution study of mice injected with either G5-Gd-Trastuzumab or G5-Gd nanoparticles. MRI signal enhancement was measured in muscle (left) and liver (right). There is minimal change in the MRI signal over the course of the study in muscle. Liver showed initial enhancement for G5-Gd-Trastuzumab and accumulation of both conjugates after 1 and 2Â days post injection